IE913214A1 - Pyridylthio or pyridyloxy alkanoic acids - Google Patents

Pyridylthio or pyridyloxy alkanoic acids

Info

Publication number
IE913214A1
IE913214A1 IE321491A IE321491A IE913214A1 IE 913214 A1 IE913214 A1 IE 913214A1 IE 321491 A IE321491 A IE 321491A IE 321491 A IE321491 A IE 321491A IE 913214 A1 IE913214 A1 IE 913214A1
Authority
IE
Ireland
Prior art keywords
pyridyl
compound
propionic acid
pharmaceutically acceptable
hydroxy
Prior art date
Application number
IE321491A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IE913214A1 publication Critical patent/IE913214A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IE321491A 1990-09-13 1991-09-12 Pyridylthio or pyridyloxy alkanoic acids IE913214A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58195890A 1990-09-13 1990-09-13

Publications (1)

Publication Number Publication Date
IE913214A1 true IE913214A1 (en) 1992-02-25

Family

ID=24327273

Family Applications (1)

Application Number Title Priority Date Filing Date
IE321491A IE913214A1 (en) 1990-09-13 1991-09-12 Pyridylthio or pyridyloxy alkanoic acids

Country Status (10)

Country Link
EP (1) EP0548291A1 (xx)
JP (1) JPH06501019A (xx)
KR (1) KR930702304A (xx)
AU (1) AU8900391A (xx)
CA (1) CA2089728A1 (xx)
IE (1) IE913214A1 (xx)
MX (1) MX9101098A (xx)
PT (1) PT98974A (xx)
WO (1) WO1992005156A1 (xx)
ZA (1) ZA917261B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
JP3181917B2 (ja) * 1992-06-30 2001-07-03 スミスクライン・ビーチャム・コーポレイション フェニルチオメチルピリジニルアルケノアート類の製造方法
ES2065234B1 (es) * 1992-10-27 1995-09-01 Smithkline Beecham Corp Compuestos para tratar enfermedades relacionadas con los leucotrienos.
AR029004A1 (es) * 1999-09-22 2003-06-04 Essential Therapeutics Inc Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
FR2885616B1 (fr) 2005-05-12 2007-06-22 Servier Lab Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885615B1 (fr) * 2005-05-12 2007-06-22 Servier Lab Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4

Also Published As

Publication number Publication date
ZA917261B (en) 1992-09-30
EP0548291A1 (en) 1993-06-30
MX9101098A (es) 1992-05-04
AU8900391A (en) 1992-04-15
CA2089728A1 (en) 1992-03-14
WO1992005156A1 (en) 1992-04-02
KR930702304A (ko) 1993-09-08
JPH06501019A (ja) 1994-01-27
PT98974A (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
EP0223593B1 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
IE913214A1 (en) Pyridylthio or pyridyloxy alkanoic acids
AU620037B2 (en) Leukotriene antagonists
EP0649412B1 (en) Pharmaceutical pyridine compounds
US4937253A (en) Ester prodrugs
EP0375348B1 (en) Leukotriene antagonists
JP2677382B2 (ja) ロイコトリエン拮抗剤
US5569677A (en) Diphenyl-2-propenoates for treating diseases associated with leukotriene B4
US5314918A (en) Leukotriene antagonists
EP0403249B1 (en) Leukotriene antagonists
AU7902991A (en) Five-membered ring alkanoic acid leukotriene antagonists
EP0732919A1 (en) Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
US5143931A (en) Leukotriene antagonists containing tetrazolyl groups
AU7769491A (en) 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists
US5189226A (en) Ortho-substituted benzaldehydes
JPH08505148A (ja) ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物
JPH09506367A (ja) 化合物